Bionano Genomics(BNGO)今日盘中大涨8.28%,引发市场广泛关注。
Bionano Genomics公司是一家致力于基因组分析的生命科学仪器公司,主要产品Saphyr系统可用于超灵敏和超特异性的结构变异检测,有助于加快新诊断和治疗靶点的发现。公司覆盖美洲、欧洲、中东和非洲以及亚太地区,主要收入来自于仪器及软件的销售。
据了解,最近Bionano Genomics一直在努力推动基因组分析业务的发展,其Saphyr系统因高精准度、高灵敏度而受到研究机构和医疗机构的青睐,公司业务前景可期。市场对公司长期增长潜力信心增强,或成为推动股价上涨的主要利好因素。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.